# AstraZeneca Pharmaceuticals LP, Frederick, MD – FDA Inspections

Source: https://www.keypedia.com/companies/astrazeneca-pharmaceuticals-lp/6f9abb75-9352-43df-b761-026089396fa3

> Inspection records and compliance data for AstraZeneca Pharmaceuticals LP in Frederick, Maryland. 9 FDA inspections on record, 4 Form 483s, 1 warning letter, last inspected June 07, 2024.

---

## Details

- Name: AstraZeneca Pharmaceuticals LP
- FEI Number: 3002617771
- Address Line 1: 633 Research Dr
- City: Frederick
- State: Maryland
- Zip Code: 21703
- Country Name: United States
- Address: 633 Research Dr, Frederick, Maryland 21703, United States
- Country: United States

## Related Documents

- [483 - AstraZeneca Pharmaceuticals LP - 2024-06-07](https://www.keypedia.com/records/483/astrazeneca-pharmaceuticals-lp/6809d725-a3ed-4b2b-b0a2-b81cc7e01672) — source: FDA, date: June 7, 2024
- [FDA Inspection 1242118 - AstraZeneca Pharmaceuticals LP - 2024-06-07](https://www.keypedia.com/records/fda_inspections/astrazeneca-pharmaceuticals-lp/f2daf178-8dee-4d6c-b0d9-aad650939e87) — source: FDA, date: June 7, 2024
- [WARNING_LETTER - AstraZeneca Pharmaceuticals LP - 2023-08-15](https://www.keypedia.com/records/warning_letter/astrazeneca-pharmaceuticals-lp/ffb41aa4-e9b4-4e4e-b72f-9cf78acb857c) — source: FDA, date: August 15, 2023
- [483 - AstraZeneca Pharmaceuticals LP - 2023-01-19](https://www.keypedia.com/records/483/astrazeneca-pharmaceuticals-lp/05295a30-e31b-4220-a8bf-8906643f78cd) — source: FDA, date: January 19, 2023
- FDA Inspection 1197584 - AstraZeneca Pharmaceuticals LP - 2023-01-19 — classification: Voluntary Action Indicated (VAI), source: FDA, date: January 19, 2023
- [EIR - AstraZeneca Pharmaceuticals LP - 2021-03-19](https://www.keypedia.com/records/eir/astrazeneca-pharmaceuticals-lp/a9e01aea-4641-46b2-9417-2ecc9c9d80aa) — source: FDA, date: March 19, 2021
- [483 - AstraZeneca Pharmaceuticals LP - 2021-03-19](https://www.keypedia.com/records/483/astrazeneca-pharmaceuticals-lp/b308dbbf-6bee-4596-8859-b6320002a2e9) — source: FDA, date: March 19, 2021
- FDA Inspection 1103507 - AstraZeneca Pharmaceuticals LP - 2019-08-26 — source: FDA, date: August 26, 2019
- [FDA Inspection 1062666 - AstraZeneca Pharmaceuticals LP - 2018-08-17](https://www.keypedia.com/records/fda_inspections/astrazeneca-pharmaceuticals-lp/e8cc1fea-3abb-4c6e-ba1a-26aa0b81097f) — classification: Voluntary Action Indicated (VAI), source: FDA, date: August 17, 2018
- [FDA Inspection 1025484 - AstraZeneca Pharmaceuticals LP - 2017-05-23](https://www.keypedia.com/records/fda_inspections/astrazeneca-pharmaceuticals-lp/36e04f1d-5b1b-4a94-9591-a591bf928ee9) — source: FDA, date: May 23, 2017
- [FDA Inspection 1001245 - AstraZeneca Pharmaceuticals LP - 2017-01-27](https://www.keypedia.com/records/fda_inspections/astrazeneca-pharmaceuticals-lp/a0a1d2cb-acc7-4166-bea1-b2603ebcba60) — source: FDA, date: January 27, 2017
- FDA Inspection 936980 - AstraZeneca Pharmaceuticals LP - 2015-07-24 — classification: No Action Indicated (NAI), source: FDA, date: July 24, 2015
- FDA Inspection 800093 - AstraZeneca Pharmaceuticals LP - 2012-09-21 — classification: No Action Indicated (NAI), source: FDA, date: September 21, 2012
- FDA Inspection 590281 - AstraZeneca Pharmaceuticals LP - 2009-06-18 — classification: No Action Indicated (NAI), source: FDA, date: June 18, 2009

## Related Companies

- [Torrent Pharmaceuticals Limited](https://www.keypedia.com/companies/torrent-pharmaceuticals-limited/801e26ba-26ed-40ab-84c9-d4ee2e24e42e)
- [Takeda Pharmaceutical Company Limited](https://www.keypedia.com/companies/takeda-pharmaceutical-company-limited/0f6bd1ca-94a2-41f0-a8dd-1af20069e6cf)
- [Adare Pharmaceuticals, Inc.](https://www.keypedia.com/companies/adare-pharmaceuticals-inc/b1aa5308-ecbd-4a48-adf0-0ed6bd2470c5)
- [EUGIA Pharma Specialities Limited](https://www.keypedia.com/companies/eugia-pharma-specialities-limited/c9c73721-7ca2-4457-89c9-f1001123e141)
- [Apothecon Pharmaceuticals Private Limited](https://www.keypedia.com/companies/apothecon-pharmaceuticals-private-limited/9fd69fd5-d0ef-458e-bdf3-b9b73b75f954)
- [NerPharMa S.r.l.](https://www.keypedia.com/companies/nerpharma-srl/12f11f8a-e70e-4598-807c-a1571bab0391)
- [POINT Biopharma USA Inc.](https://www.keypedia.com/companies/point-biopharma-usa-inc/f4a8cb71-7a5c-4407-a6c8-6765aacfb8da)
- [Qilu Antibiotics Pharmaceutical Co. , Ltd.](https://www.keypedia.com/companies/qilu-antibiotics-pharmaceutical-co-ltd/f1c696c7-317f-4fb9-92a1-df8381af004c)
- [Pharmaron (Ningbo) Technology Development Co., Ltd.](https://www.keypedia.com/companies/pharmaron-ningbo-technology-development-co-ltd/c40334bd-b474-48eb-91c6-51a228da2a42)
- [Cipla, Ltd.](https://www.keypedia.com/companies/cipla-ltd/f726d9c8-4fe7-456e-848c-f9ef86f00e4f)

## Related Officers

- [FDA Biologics Investigator](https://www.keypedia.com/people/viviana-matta/6fecf0ca-0edc-4538-a57e-72642f41b5c7)
- [issuing_officer](https://www.keypedia.com/people/haoheng-yan/404af95d-404c-4227-b50e-544a96adc24a)
- [issuing_officer](https://www.keypedia.com/people/zhao-wang/51081e23-1891-4c93-9488-f578511e0a0e)
- [Sena G. Dissmeyer](https://www.keypedia.com/people/sena-g-dissmeyer/4dbb1255-95e4-402b-8bb3-75c4f7940c13)
- [Consumer Safety Officer ](https://www.keypedia.com/people/anastasia-m-shields/a22b8d52-e3f9-4e61-aa3f-6f03ff2f59df)